IP Library › Granted Patent US 7,109,030
Granted Patent B2
US 7,109,030 · App. 10/218,325 · Granted Sep 19, 2006

Methods of therapy and diagnosis using insulin-like growth factor binding protein-like polypeptides and polynucleotides

Assignee: Nuvelo, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,109,030
App. No.
10/218,325
Granted
Sep 19, 2006
Kind
B2
Abstract

The invention provides novel polynucleotides and polypeptides encoded by such polynucleotides and mutants or variants thereof that correspond to novel human secreted IGFBP-like polypeptides. Other aspects of the invention include vectors containing processes for producing novel human secreted IGFBP-like polypeptides, compositions, and methods of use for such polypeptides including in cancer.

Claims (10)

1. An isolated polypeptide comprising an amino acid sequence which is at least 98% identical to the amino acid sequence selected from the group consisting of SEQ ID NO: 6 or the mature protein portion thereof.

2. A composition comprising the polypeptide of claim 1 and a carrier.

3. A method for identifying a compound that binds to the polypeptide of claim 1 , comprising:

a) contacting the compound with the polypeptide of claim 1 under conditions and for a time sufficient to form a polypeptide/compound complex; and

b) detecting the complex, so that if the polypeptide/compound complex is detected, a compound that binds to the polypeptide of claim 1 is identified.

4. A method for identifying a compound that binds to the polypeptide of claim 1 , comprising:

a) contacting the compound with the polypeptide of claim 1 , in a cell, for a time sufficient to form a polypeptide/compound complex, wherein the complex drives expression of a reporter gene sequence in the cell; and

b) detecting the complex by detecting reporter gene sequence expression, so that if the polypeptide/compound complex is detected, a compound that binds to the polypeptide of claim 1 is identified.

5. An in vitro method of suppressing the growth of a gastric or cervical cancer cell, comprising the step of administering a composition to said cells in an amount effective to suppress the growth of said cancer cell, wherein said composition comprises a polypeptide of SEQ ID NO: 6, or the mature protein portion thereof.

6. An isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 6 or the mature protein portion thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2006
From: ASUNDI, VINOD; DRMANAC, RADOJE T.; DEDERA, DOUGLAS; TANG, Y. TOM; YAMAZAKI, VICTORIA
To: NUVELO, INC.
Reel/Frame 016981/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 17, 2005
From: YAMAZAKI, VICTORIA; TANG, Y. TOM; DEDERA, DOUGLAS; DRMANAC, RADOJE T; ASUNDI, VINOD
To: NUVELO, INC.
Reel/Frame 016415/0294 →
Continuity (5)
Continuation In Part 1008713700 · Feb 27, 2002
Continuation In Part 0978474800 · Feb 14, 2001
Continuation In Part 0964916700 · Aug 23, 2000
Continuation In Part 0954021700 · Mar 31, 2000
Related Publication 20060073514A1 · Apr 6, 2006